Sirolimus (INN/USAN), also known as rapamycin, is a macrolide produced by the
bacterium Streptomyces hygroscopicus. It has immunosuppressant functions in ...
Sirolimus may increase the risk that you will develop an infection or cancer,
especially lymphoma (cancer of a part of the immune system) or skin cancer.
Sirolimus is used together with other medicines to prevent the body from rejecting
a ... Sirolimus works by preventing the white blood cells from getting rid of the ...
It is bioactive only when bound to immunophilins. Sirolimus is a potent
immunosuppressant and possesses both antifungal and antineoplastic
Find patient medical information for sirolimus oral on WebMD including its uses,
side effects and safety, interactions, pictures, warnings and user ratings.
Sirolimus (rapamycin), the latest one, is still being developed. It seems a very
promising immunosuppressive drug which could in future replace calcineurin ...
sirolimus: A natural macrocyclic lactone produced by the bacterium Streptomyces
hygroscopicus, with immunosuppressant properties. In cells, sirolimus binds to ...
Sirolimus (trade name Rapamune™) is a selective immune suppressing drug. It
is most commonly used in patients that have a transplanted kidney to prevent ...
Consumer information about the medication SIROLIMUS - ORAL (Rapamune),
includes side effects, drug interactions, recommended dosages, and storage ...
Nov 24, 2014 ... Conclusions Sirolimus was associated with a reduction in the risk of malignancy
and non-melanoma skin cancer in transplant recipients.